Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Simple Drug Change Could Save Medicare Hundreds of Millions
Alzheimer's: Simple Drug Change Could Save Medicare Hundreds of Millions
Medicare could save millions of dollars every year by changing the way they package Alzheimer's medication.
Big vials of Alzheimer's drug could cost Medicare $336M
Medicare could be throwing away as much as $336 million worth of a costly Alzheimer's drug each year because the size of vials is too big, UCLA researchers estimate. Why it matters: The findings, published Monday in JAMA Internal Medicine,
Changing Alzheimer's drug vial size might save big money for Medicare
A simple tweak in available vial sizes of the breakthrough Alzheimer's drug Leqembi could save Medicare hundreds of millions of dollars each year, a new analysis claims.
Alzheimer's Drug in Smaller Vial Sizes Could Save Medicare Hundreds of Millions
Current vial sizes may result in 5.8% of the Alzheimer's disease drug being thrown away, representing $1,619 in wasted Medicare spending per patient per year, reported researchers led by John Mafi, MD,
Smaller vial for Alzheimer's drug could save Medicare $366M per year: Study
A new study suggests that Medicare could save up to $366 million annually by introducing a new vial size for Alzheimer's drug lecanemab, which is currently only available in single-use, 500- and 200-milligram vials.
Medical News Today
1d
Could a once-daily pill for seizures also treat Alzheimer's disease?
A recent study suggests that a drug approved for the treatment of seizures may also help treat Alzheimer's in people who do ...
Rolling Out
7d
New drug offers hope in fight against Alzheimer’s disease
Alzheimer's is a brain disease that causes memory loss and thinking problems. It gets worse over time and is the most common ...
Opinion
The Daily Record (Maryland)
15h
Opinion
MD’s IGC Pharma enrolls patients in Phase 2 trial for Alzheimer’s dementia drug
Potomac-based IGC Pharma Inc. Thursday announced enrollment of patients at the Baycrest Academy for Research and Education in ...
16h
Annovis Bio To Continue Alzheimer's Disease Clinical Trials
Annovis has limited cash reserves and faces challenges in financing further trials, making the future of Buntanetap uncertain ...
Rolling Out
6d
7 exciting breakthroughs in Alzheimer’s research: New drug shows promise
A groundbreaking study has unveiled a potential game-changer in the fight against Alzheimer's disease. Scientists have ...
McKnight's Long-Term Care News
11d
Promising new Alzheimer’s drug candidate developed by international research team
A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of ...
pharmaphorum
1d
Australia joins EU in turning down Alzheimer's drug Leqembi
Australia's Therapeutic Goods Administration (TGA) has said it won't approve Eisai and Biogen's Alzheimer's disease therapy ...
3d
Eli Lilly's Alzheimer's Drug Raises Hopes but Faces Regulatory Hurdles in Europe
Eli Lilly invests £279M in the UK to boost life sciences, while its Alzheimer's drug, donanemab, faces European regulatory ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback